scholarly journals Association of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients in Dakar

2021 ◽  
Vol 15 (3) ◽  
pp. 43-48
Author(s):  
Oumou Kesso Barry Nènè ◽  
Djite Moustapha ◽  
Matar Kandji Pape ◽  
Hadji Malick Ndour El ◽  
Assane Ndour Michel ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus

Heritability, parental transmission and environment correlation of pediatric-onset type 2 diabetes mellitus and metabolic syndrome-related traits

2017 ◽  
Vol 126 ◽  
pp. 151-159 ◽  
Author(s):  
América L. Miranda-Lora ◽  
Jenny Vilchis-Gil ◽  
Mario Molina-Díaz ◽  
Samuel Flores-Huerta ◽  
Miguel Klünder-Klünder
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Onset Type ◽  
Parental Transmission ◽  
Pediatric Onset

Study of co-morbidities in patients of chronic obstructive pulmonary disease at a tertiary hospital

2021 ◽  
Vol 19 (3) ◽  
pp. 122-125
Author(s):  
Rohit Chordia ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Tertiary Hospital ◽  
Systemic Hypertension ◽  
Cardiac Abnormalities ◽  
Copd Patients ◽  
Obstructive Sleep

Background: Comorbidities are important events in the natural history of the disease and have a negative effect on the morbidity and mortality of COPD patients. It is increasingly recognized that, many patients with COPD have co-morbidities that have a major impact on quality of life and survival. Present study aims at studying the prevalence and effects of comorbidities in COPD patients at a tertiary hospital. Material and Methods: Present study was cross sectional, observational study conducted in COPD patients, diagnosed for more than 5 years, underwent investigations for various comorbidities. Results: In present study, 130 COPD patients were studied for various co-morbidities. Majority of cases were from 50 -64 years age group (49.23 %) and were male (97.69 %). Smoking was major factor noted among cases (73.85 %), out of them 23.96 % were current smoker. Mean duration since quitting of smoking was 7.24 ± 5.83 years. Comorbidities noted in present study were systemic hypertension (42.31 %), GERD and gastric ulceration (31.54 %), type 2 diabetes mellitus (30.77 %), metabolic syndrome (29.23 %), anemia (11.54 %), left sided cardiac abnormalities (10.77 %), depression (8.46 %), obstructive sleep apnea (6.92 %), ischemic heart disease (6.15 %), osteoporosis (4.62 %), bronchiectasis (2.31 %) and lung cancer (0.77 %). Conclusion: Comorbidities noted in present study were hypertension, GERD, type 2 diabetes mellitus, metabolic syndrome, anaemia, left sided cardiac abnormalities and depression.

Sign in / Sign up

Export Citation Format

Share Document